POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
For the last 30 years, angiotensin-converting enzyme (ACE) inhibitors have been playing a key role in the management of arterial hypertension (AH) and related cardiovascular disease. This review discusses the mechanisms of action and organo-protective effects of ACE inhibitors. Enalapril is the most...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2013-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/123 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849408400886071296 |
|---|---|
| author | A. G. Evdokimova V. V. Evdokimov |
| author_facet | A. G. Evdokimova V. V. Evdokimov |
| author_sort | A. G. Evdokimova |
| collection | DOAJ |
| description | For the last 30 years, angiotensin-converting enzyme (ACE) inhibitors have been playing a key role in the management of arterial hypertension (AH) and related cardiovascular disease. This review discusses the mechanisms of action and organo-protective effects of ACE inhibitors. Enalapril is the most extensively studied and widely used in the international clinical practice ACE inhibitor. The authors analyse the results of the studies on enalapril therapy in AH, coronary heart disease (CHD), chronic heart failure, metabolic syndrome, and postmenopause. It has been demonstrated that the combination antihypertensive therapy with a β-adrenoblocker nebivolol, enalapril, and hydrochlorothiazide (such as Berlipril® Plus) is safe and effective in patients with AH and CHD. |
| format | Article |
| id | doaj-art-92c2a48d54e9430cadbc96cbd0f58d09 |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2013-02-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-92c2a48d54e9430cadbc96cbd0f58d092025-08-20T03:35:47Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-02-01121808710.15829/1728-8800-2013-1-80-87123POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASEA. G. Evdokimova0V. V. Evdokimov1A.I. Evdokimov Moscow State Medico-Stomatological University, MoscowA.I. Evdokimov Moscow State Medico-Stomatological University, MoscowFor the last 30 years, angiotensin-converting enzyme (ACE) inhibitors have been playing a key role in the management of arterial hypertension (AH) and related cardiovascular disease. This review discusses the mechanisms of action and organo-protective effects of ACE inhibitors. Enalapril is the most extensively studied and widely used in the international clinical practice ACE inhibitor. The authors analyse the results of the studies on enalapril therapy in AH, coronary heart disease (CHD), chronic heart failure, metabolic syndrome, and postmenopause. It has been demonstrated that the combination antihypertensive therapy with a β-adrenoblocker nebivolol, enalapril, and hydrochlorothiazide (such as Berlipril® Plus) is safe and effective in patients with AH and CHD.https://cardiovascular.elpub.ru/jour/article/view/123arterial hypertensioncoronary heart diseaseangiotensinconverting enzyme inhibitorsberlipril®berlipril® plus |
| spellingShingle | A. G. Evdokimova V. V. Evdokimov POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE Кардиоваскулярная терапия и профилактика arterial hypertension coronary heart disease angiotensinconverting enzyme inhibitors berlipril® berlipril® plus |
| title | POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE |
| title_full | POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE |
| title_fullStr | POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE |
| title_full_unstemmed | POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE |
| title_short | POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE |
| title_sort | potential of angiotensin converting enzyme inhibitors in the treatment of patients with arterial hypertension and coronary heart disease |
| topic | arterial hypertension coronary heart disease angiotensinconverting enzyme inhibitors berlipril® berlipril® plus |
| url | https://cardiovascular.elpub.ru/jour/article/view/123 |
| work_keys_str_mv | AT agevdokimova potentialofangiotensinconvertingenzymeinhibitorsinthetreatmentofpatientswitharterialhypertensionandcoronaryheartdisease AT vvevdokimov potentialofangiotensinconvertingenzymeinhibitorsinthetreatmentofpatientswitharterialhypertensionandcoronaryheartdisease |